Role of channel activation in cognitive enhancement mediated by α7 nicotinic acetylcholine receptors

British Journal of Pharmacology

Volumn 158, Issue 6, 2009, Pages 1486-1494

  Briggs, Clark A ^a   Grønlien, Jens Halvard ^a   Curzon, Peter ^a   Timmermann, Daniel B ^b   Ween, Hilde ^a   Thorin Hagene, Kirsten ^a   Kerr, Paige ^a   Anderson, David J ^a   Malysz, John ^a   Dyhring, Tino ^b   Olsen, Gunnar M ^b   Peters, Dan ^b   Bunnelle, William H ^a   Gopalakrishnan, Murali ^a  

^a ABBOTT LABORATORIES   (United States)

^b NEUROSEARCH A S   (Denmark)

Author keywords

Biopharmaceuticals; Desensitization; Functional systems; Learning and memory; Ligand gated ion channels; Nicotinic acetylcholine receptor

Indexed keywords

BUNGAROTOXIN RECEPTOR; NICOTINIC AGENT; NS 6740; NS 6784; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DESENSITIZATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MEMORY CONSOLIDATION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT;

ALLOSTERIC REGULATION; ANIMALS; AVOIDANCE LEARNING; AZABICYCLO COMPOUNDS; BEHAVIOR, ANIMAL; CELL LINE; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FURANS; HUMANS; MALE; MICE; NICOTINIC AGONISTS; OOCYTES; OXADIAZOLES; PYRIDAZINES; PYRROLES; RATS; RECEPTORS, NICOTINIC; XENOPUS LAEVIS;

EID: 70350547578     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00426.x     Document Type: Article

References (50)

1. Alkondon M, Pereira EFR, Wonnacott S, Albuquerque EX (1992). Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol Pharmacol 41 : 802 808.
2. Alkondon M, Pereira EFR, Albuquerque EX (1998 Bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 810 : 257 263.
3. 3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5- aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain. J Pharmacol Exp Ther 324 : 179 187.
4. Arredondo J, Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Kummer W et al. (2002). Central role of α7 nicotinic receptor in differentiation of the stratified squamous epithelium. J Cell Biol 159 : 325 336.
5. Bitner RS, Bunnelle WH, Anderson DJ, Briggs CA, Buccafusco J, Curzon P et al. (2007). Broad-spectrum efficacy across cognitive domains by α7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. J Neurosci 27 : 10578 10587.
6. Boess FG, De Vry J, Erb C, Flessner T, Hendrix M, Luithle J et al. (2007). The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2- carboxamide improves working and recognition memory in rodents. J Pharmacol Exp Ther 321 : 716 725.
7. Briggs CA, McKenna DG (1996). Effect of MK-801 at the human α7 nicotinic acetylcholine receptor. Neuropharmacology 35 : 407 414.
8. Briggs CA, McKenna DG (1998). Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists. Neuropharmacology 37 : 1095 1102.
9. Briggs CA, McKenna DG, Piattoni-Kaplan M (1995). Human α7 nicotinic acetylcholine receptor responses to novel ligands. Neuropharmacology 34 : 583 590.
10. Briggs CA, McKenna DG, Monteggia LM, Touma E, Roch J-M, Arneric SP et al. (1999). Gain of function mutation of the α7 nicotinic acetylcholine receptor: distinct pharmacology of the human α7V274T variant. Eur J Pharmacol 366 : 301 308.
11. Briggs CA, Gubbins EJ, Marks MJ, Putman CB, Thimmapaya R, Meyer MD et al. (2006). Untranslated region dependent exclusive expression of high-sensitivity subforms of α4β2 and α3β2 nicotinic acetylcholine receptors. Mol Pharmacol 70 : 227 240.
12. Briggs CA, Schrimpf MR, Anderson DJ, Gubbins EJ, Gronlien JH, Hakerud M et al. (2008 7 Nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues. Br J Pharmacol 153 : 1054 1061.
13. Bruggmann D, Lips KS, Pfeil U, Haberberger RV, Kummer W (2002). Multiple nicotinic acetylcholine receptor α-subunits are expressed in the arterial system of the rat. Histochem Cell Biol 118 : 441 447.
14. Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP, Bertrand D (1996). Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study. J Neurosci 16 : 7880 7891.
15. Coggan JS, Bartol TM, Esquenazi E, Stiles JR, Lamont S, Martone ME et al. (2005). Evidence for ectopic neurotransmission at a neuronal synapse. Science 309 : 446 451.
16. Dickinson JA, Hanrott KE, Mok MH, Kew JN, Wonnacott S (2007). Differential coupling of α7 and non-α7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells. J Neurochem 100 : 1089 1096.
17. Dunlop J, Roncarati R, Jow B, Bothmann H, Lock T, Kowal D et al. (2007). In vitro screening strategies for nicotinic receptor ligands. Biochem Pharmacol 74 : 1172 1181.
18. Edelstein SJ, Changeux J-P. (1996). Allosteric proteins after thirty years: the binding and state functions of the neuronal α7 nicotinic acetylcholine receptors. Experientia 52 : 1083 1090.
19. Egleton RD, Brown KC, Dasgupta P (2008). Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 29 : 151 158.
20. Elliott KJ, Ellis SB, Berckhan KJ, Urrutia A, Chavez-Noriega LE, Johnson EC et al. (1996). Comparative structure of human neuronal α2-α7 and β2-β4 nicotinic acetylcholine receptor subunits and functional expression of the α2, α3, α4, α7, β2, and β4 subunits. J Mol Neurosci 7 : 217 228.
21. Evans NM, Bose S, Benedetti G, Zwart R, Pearson KH, McPhie GI et al. (2003). Expression and functional characterisation of a human chimeric nicotinic receptor with α6β4 properties. Eur J Pharmacol 466 : 31 39. (Pubitemid 36385088)
22. Fenster CP, Rains MF, Noerager B, Quick MW, Lester RAJ (1997). Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17 : 5747 5759.
23. Fujii YX, Fujigaya H, Moriwaki Y, Misawa H, Kasahara T, Grando SA et al. (2007). Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor α7 subunit gene knockout mice. J Neuroimmunol 189 : 69 74.
24. Galzi J-L, Devillers-Thiéry A, Hussy N, Bertrand S, Changeux J-P, Bertrand D (1992). Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature 359 : 500 505.
25. Gotti C, Hanke W, Maury K, Moretti M, Ballivet M, Clementi F et al. (1994). Pharmacology and biophysical properties of α7 and α7-α8 α-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur J Neurosci 6 : 1281 1291.
26. Gotti C, Carbonnelle E, Moretti M, Zwart R, Clementi F (2000). Drugs selective for nicotinic receptor subtypes: a real possibility or a dream? Behav Brain Res 113 : 183 192.
27. Grønlien JH, Haakerud M, Ween H, Thorin-Hagene K, Briggs CA, Gopalakrishnan M et al. (2007). Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Mol Pharmacol 72 : 715 724.
28. Guo JZ, Liu Y, Sorenson EM, Chiappinelli VA (2005). Synaptically released and exogenous ACh activate different nicotinic receptors to enhance evoked glutamatergic transmission in the lateral geniculate nucleus. J Neurophysiol 94 : 2549 2560.
29. Hurst RS, Hajos M, Raggenbass M, Wall TM, Higdon NR, Lawson JA et al. (2005). A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J Neurosci 25 : 4396 4405.
30. Jones IW, Wonnacott S (2004). Precise localization of α7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. J Neurosci 24 : 11244 11252.
31. Jones IW, Westmacott A, Chan E, Jones RW, Dineley K, O'Neill MJ et al. (2006 7 Nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes. J Mol Neurosci 30 : 83 84.
32. Kem WR, Mahnir VM, Prokai L, Papke RL, Cao X, LeFrancois S et al. (2004). Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy) benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration. Mol Pharmacol 65 : 56 67.
33. Li XW, Wang H (2006). Non-neuronal nicotinic α7 receptor, a new endothelial target for revascularization. Life Sci 78 : 1863 1870.
34. Lockman PR, Van Der Schyf CJ, Abbruscato TJ, Allen DD (2005). Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine. J Neurochem 94 : 37 44.
35. Maggi L, Palma E, Eusebi F, Moretti M, Balestra B, Clementi F et al. (1999). Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick α7 nicotinic receptor. Br J Pharmacol 126 : 285 295.
36. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D et al. (2006). Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63 : 630 638.
37. Pichat P, Bergis OE, Terranova JP, Urani A, Duarte C, Santucci V et al. (2007). SSR180711, a novel selective α7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32 : 17 34.
38. A receptor modulators. Expert Opin Ther Pat 17 : 1365 1377.
39. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC et al. (2004). Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65 : 1526 1535.
40. Sands SB, Costa ACS, Patrick JW (1993). Barium permeability of neuronal nicotinic receptor α7 expressed in Xenopus oocytes. Biophys J 65 : 2614 2621.
41. 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13 : 596 604.
42. Sudweeks SN, Yakel JL (2000). Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol 527 : 515 528.
43. Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Xue IC et al. (1997). ABT-089 [2-methyl-3(2-(S)-pyrrolidinylmethoxy)pyridine] : I. A potent and selective cholinergic channel modulator with neuroprotective properties. J Pharmacol Exp Ther 283 : 235 246.
44. Tietje KR, Anderson DJ, Bitner RS, Blomme EA, Brackenmeyer PJ, Briggs CA et al. (2008). Preclinical characterization of A-582941: a novel α7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties. CNS Drug Rev 14 : 65 82.
45. Timmermann DB, Grønlien JH, Kohlhaas KL, Nielsen E, Dam E, Jørgensen TD et al. (2007). An allosteric modulator of the α7 nicotinic acetylcholine receptor displaying memory enhancing properties. J Pharmacol Exp Ther 323 : 294 307.
46. Trumbull JD, Maslana ES, McKenna DG, Nemcek TA, Niforatos W, Pan JY et al. (2003). High throughput electrophysiology using a fully automated, multiplexed recording system. Receptors Channels 9 : 19 28.
47. Turek JW, Kang CH, Campbell JE, Arneric SP, Sullivan JP (1995). A sensitive technique for the detection of the α7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. J Neurosci Methods 61 : 113 118.
48. Verbitsky M, Rothlin CV, Katz E, Elgoyhen AB (2000). Mixed nicotinic-muscarinic properties of the α9 nicotinic cholinergic receptor. Neuropharmacology 39 : 2515 2524.
49. Wishka DG, Walker DP, Yates KM, Reitz SC, Jia S, Myers JK et al. (2006). Discovery of N-[(3r)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5- carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure-activity relationship. J Med Chem 49 : 4425 4436.
50. Wonnacott S, Barik J, Dickinson J, Jones IW (2006). Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. J Mol Neurosci 30 : 137 140.